HighVista Strategies LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
HighVista Strategies LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2022$612,000
-58.7%
12,108
-12.5%
0.37%
-68.8%
Q4 2021$1,483,000
+13.5%
13,843
+8.9%
1.18%
+36.5%
Q3 2021$1,307,000
+68.9%
12,716
+44.4%
0.86%
+57.6%
Q2 2021$774,000
+83.8%
8,805
+63.2%
0.55%
+57.3%
Q2 2020$421,0005,3960.35%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders